535 related articles for article (PubMed ID: 10404910)
21. Plasma levels of apolipoprotein E and cognitive function in old age.
Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG
Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.
Yip AG; Brayne C; Easton D; Rubinsztein DC;
J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
24. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function.
Carmelli D; DeCarli C; Swan GE; Kelly-Hayes M; Wolf PA; Reed T; Guralnik JM
J Gerontol A Biol Sci Med Sci; 2000 Feb; 55(2):M103-9. PubMed ID: 10737693
[TBL] [Abstract][Full Text] [Related]
25. Cognitive resilience to apolipoprotein E ε4: contributing factors in black and white older adults.
Kaup AR; Nettiksimmons J; Harris TB; Sink KM; Satterfield S; Metti AL; Ayonayon HN; Yaffe K;
JAMA Neurol; 2015 Mar; 72(3):340-8. PubMed ID: 25599330
[TBL] [Abstract][Full Text] [Related]
26. APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline.
Bangen KJ; Beiser A; Delano-Wood L; Nation DA; Lamar M; Libon DJ; Bondi MW; Seshadri S; Wolf PA; Au R
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1361-9. PubMed ID: 23601373
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women.
Yaffe K; Cauley J; Sands L; Browner W
Arch Neurol; 1997 Sep; 54(9):1110-4. PubMed ID: 9311354
[TBL] [Abstract][Full Text] [Related]
28. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.
Ballard CG; Morris CM; Rao H; O'Brien JT; Barber R; Stephens S; Rowan E; Gibson A; Kalaria RN; Kenny RA
Neurology; 2004 Oct; 63(8):1399-402. PubMed ID: 15505155
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein epsilon4 allele and problems with orientation are associated with a persistent decline in cognition in community-dwelling elderly persons.
Wayne SJ; Vellas BJ; Brodie SG; Garry PJ; Baumgartner RN
J Gerontol A Biol Sci Med Sci; 2005 Mar; 60(3):375-9. PubMed ID: 15860477
[TBL] [Abstract][Full Text] [Related]
30. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
31. Interactive effect of APOE genotype and blood pressure on cognitive decline: the PATH through life study.
Andrews S; Das D; Anstey KJ; Easteal S
J Alzheimers Dis; 2015; 44(4):1087-98. PubMed ID: 25672766
[TBL] [Abstract][Full Text] [Related]
32. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins.
Carmelli D; Swan GE; Reed T; Miller B; Wolf PA; Jarvik GP; Schellenberg GD
Neurology; 1998 Jun; 50(6):1580-5. PubMed ID: 9633697
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
Batterham PJ; Bunce D; Cherbuin N; Christensen H
Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
[TBL] [Abstract][Full Text] [Related]
35. The association between delirium and the apolipoprotein E epsilon4 allele in the elderly.
van Munster BC; Korevaar JC; de Rooij SE; Levi M; Zwinderman AH
Psychiatr Genet; 2007 Oct; 17(5):261-6. PubMed ID: 17728664
[TBL] [Abstract][Full Text] [Related]
36. Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.
Hayden KM; Zandi PP; West NA; Tschanz JT; Norton MC; Corcoran C; Breitner JC; Welsh-Bohmer KA;
Arch Neurol; 2009 Nov; 66(11):1378-83. PubMed ID: 19901170
[TBL] [Abstract][Full Text] [Related]
37. Age-related trends in cardiovascular morbidity and physical functioning in the elderly: the Cardiovascular Health Study.
Bild DE; Fitzpatrick A; Fried LP; Wong ND; Haan MN; Lyles M; Bovill E; Polak JF; Schulz R
J Am Geriatr Soc; 1993 Oct; 41(10):1047-56. PubMed ID: 8409149
[TBL] [Abstract][Full Text] [Related]
38. Do apolipoprotein E genotype and educational attainment predict the rate of cognitive decline in normal aging? A 12-year follow-up of the Maastricht Aging Study.
Van Gerven PW; Van Boxtel MP; Ausems EE; Bekers O; Jolles J
Neuropsychology; 2012 Jul; 26(4):459-72. PubMed ID: 22642392
[TBL] [Abstract][Full Text] [Related]
39. Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures.
Lui LY; Stone K; Cauley JA; Hillier T; Yaffe K
J Am Geriatr Soc; 2003 Jan; 51(1):38-43. PubMed ID: 12534843
[TBL] [Abstract][Full Text] [Related]
40. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
